Tagged Articles

attorneys 326 articles

Risperdal makers attempt to discredit former FDA chief in gynecomastia lawsuit


Johnson & Johnson attorneys attempted to discredit former Food and Drug Administration (FDA) chief who testified against the company in a lawsuit claiming its antipsychotic drug Risperdal causes adolescent boys to grow breasts. Former FDA Commissioner David Kessler testified in front of a Philadelphia jury last week in the gynocomastia lawsuit saying, “What (Johnson & Johnson and its subsidiary Janssen Pharmaceuticals) want to convey here, as you see in their own words, doesn’t match what the data show and, to me, that’s not telling the whole story, especially when you’re talking about adverse events that are significant. “The one thing you ... Read More

New lawsuit claims baby powder for personal hygiene caused ovarian cancer

baby powder contains talc

Johnson & Johnson faces a new lawsuit claiming the use of its talcum powder for feminine hygiene caused ovarian cancer. Judith Harlan claims she used the company’s baby powder regularly on her genitals for nearly 50 years, trusting the product’s label that it safe even for babies. In 2013, Judith was diagnosed with ovarian cancer, one of the most deadly forms of cancer among women. Judith learned that in 1971 the first study emerged showing a link between talcum powder and cancer. In 1982, another study showed that women who repeatedly used talcum powder on their genitals for personal hygiene were ... Read More

Judge allows new expert for plaintiffs in Risperdal gynecomastia lawsuit


A Philadelphia State judge rejected Johnson & Johnson subsidiary Janssen Pharmaceutical attorney’s claims that the company was prejudiced by a new expert witness for plaintiffs in a lawsuit alleging Janssen’s antipsychotic drug Risperdal caused a boy to grow large female breasts. The condition is known as gynocomastia. Defense attorneys argued that Janssen had been disadvantaged by the new expert’s testimony, which contained different opinions than those of a previous expert witness. The previous witness suddenly withdrew from the case after defense attorneys accused the doctor of failing to comply with state law when he examined the plaintiff in his home state ... Read More

Judge tells Janssen attorney to ‘play by rules’ in Risperdal gynecomastia lawsuit


A Pennsylvania State judge told an attorney for Johnson & Johnson subsidiary Janssen Pharmaceuticals that she had to “play by the rules to get a fair trial,” in a lawsuit alleging the company’s antipsychotic drug Risperdal caused a boy to grow large female breasts. “There are some rules of civil procedure in this state and therefore we’re going to follow them,” Philadelphia County Court of Common Pleas Judge Ramy Djerassi told the defense attorney when pointing out that Janssen biochemist Ivo Caers could not testify on pharmaceutical regulations in the United States. Caers could only speak to his own experience ... Read More

Judge slaps Takeda with additional damages in Actos bladder cancer lawsuit

Actos (pioglitazone) Type 2 diabetes medication

A Pennsylvania judge refused to overturn a $2 million verdict against Takeda Pharmaceuticals Inc. involving claims that its type 2 diabetes drug Actos caused bladder cancer, and slapped the drug company with nearly $100,000 in additional damages for the delay. Plaintiff Frances Wisniewski filed the lawsuit in Philadelphia Court of Common Pleas in July 2012 claiming she developed bladder cancer after taking Actos for seven years. In August 2011, the Food and Drug Administration (FDA) ordered Takeda to update the safety label of Actos to include warnings for bladder cancer risk in patients who used the drug for more than a ... Read More

Mass tort docket established for several Xarelto bleeding risk lawsuits


About 75 lawsuits against Bayer Healthcare Pharmaceuticals and Janssen Pharmaceuticals alleging major bleeding risks with the companies’ anticoagulant Xarelto have been moved into a mass tort docket by Philadelphia Court of Common Pleas Administrative Judge Kevin Dougherty and will be transferred to the court’s Complex Litigation Center. “The creation of a mass tort program benefits the Court system and the parties by eliminating duplicative discovery, inconsistent rulings and promoting the efficient prosecution and resolutions of similar cases,” said an attorney for the plaintiffs. “The defendants have strong ties to Pennsylvania making this an appropriate and convenient forum.” Xarelto is an ... Read More

Judge shoots down mistrial bid by Janssen in Risperdal gynecomastia lawsuit


A Pennsylvania state judge rejected a bid for a mistrial this week from Johnson & Johnson unit Janssen Pharmaceuticals in a lawsuit alleging the company’s antipsychotic drug Risperdal caused an adolescent boy to grow large female breasts. Attorneys for Janssen argued that a mistrial was warranted because plaintiff’s attorneys were trying to pass off an expert witness to testify about Risperdal side effects when that expert, a physician in Pennsylvania, was not licensed in Alabama, where the plaintiffs lived and where physician had examined the boy. The physician, Dr. David Goldstein, had opted to withdraw from the Risperdal gynecomastia lawsuit ... Read More

Personal injury lawsuit claims blood thinner Xarelto caused serious bleeding event


Sonja Lemoins says the blood thinner Xarelto she was taking to prevent strokes caused her to suffer a serious bleeding event. She is suing Janssen Research and Development and Bayer Healthcare Pharmaceuticals, makers of Xarelto, claiming the companies failed to warn doctors or their patients that using Xarleto could cause potentially fatal internal bleeds. Xarelto is in a newer class of anticoagulants designed to prevent or treat blood clots in some heart patients and patients who have recently undergone hip or knee replacement surgery. Other drugs in this class include Pradaxa. The drug companies spent at least $11 million to promote ... Read More

Plaintiffs attorneys say transvaginal mesh victims should not have to prove their injuries

transvaginal mesh

Johnson & Johnson’s request that plaintiffs in a multidistrict litigation (MDL) who allege the company’s transvaginal mesh was defective prove they were injured is ludicrous and nothing more than a delay tactic, plaintiffs attorneys said responding to a Jan. 13 motion by the consumer health care and pharmaceutical giant. Johnson & Johnson and its subsidiary Ethicon Inc., asked that the near-24,000 plaintiffs in the multidistrict litigation prove thy were injured by the company’s transvaginal mesh, and asked the court to require every plaintiff’s attorney to answer under oath certain questions on how plaintiffs were solicited. The companies claim that “unscrupulous” ... Read More

Community Health Systems patient information compromised in massive data breach

computer security login1

Community Health Systems, Inc., has admitted data from its affiliated physician practices and clinics was breached in what it terms a “foreign-based cyber-attack” on its computer network. Patient information was compromised. The cyberattack occurred in April and June 2014 but was not publicly disclosed until August 2014. Community Health Systems is the largest operator of acute-care hospitals in the United States. Its affiliates own, operate or lease 206 hospitals in 29 states, with approximately 31,100 licensed beds. In a note published on the CHS website, Andi Bosshart, SVP, Corporate Compliance and Privacy Officer for Community Health Systems Professional Services Corporation ... Read More